Table 3 Toxicity

Median total hospital days

3

0

.03

3

0

.08

 (IQR)

(0–9)

(0–4)

(0–9)

(0–4)

Hospitalizations

.04

.04

 Yes

62 (43.1%)

28 (41.2%)

60 (43.5%)

21 (40.4%)

 No

49 (34.0%)

33 (48.5%)

46 (33.3%)

26 (50.0%)

 Not stated

33 (22.9%)

7 (10.3%)

32 (23.2%)

5 (9.6%)

Feeding tube during RT

.11

.09

 Yes

72 (50.0%)

26 (38.2%)

67 (48.6%)

18 (34.6%)

 No

72 (50.0%)

42 (61.8%)

71 (51.5%)

34 (65.4%)

Weight loss >10%

.17

.06

 Yes

72 (50.0%)

30 (44.1%)

71 (51.4%)

23 (44.2%)

 No

36 (25.0%)

24 (35.3%)

33 (23.9%)

21 (40.4%)

 Not stated

36 (25.0%)

14 (20.6%)

34 (24.6%)

8 (15.4%)

Grade ≥ 3 mucositis

.47

.25

 Yes

35 (24.3%)

19 (27.9%)

33 (23.9%)

17 (32.7%)

 No

85 (59.0%)

36 (52.9%)

83 (60.1%)

28 (53.8%)

 Not stated

24 (16.7%)

13 (19.1%)

22 (15.9%)

7 (13.5%)

Grade ≥ 3 dermatitis

.54

.70

 Yes

6 (4.2%)

4 (5.9%)

6 (4.3%)

3 (5.8%)

 No

115 (79.9%)

51 (75.0%)

111 (80.4%)

42 (80.8%)

 Not stated

23 (16.0%)

13 (19.1%)

21 (15.2%)

7 (13.5%)

Feeding tube at last follow-up

.46

.15

 Yes

43 (29.9%)

17 (25.0%)

41 (29.7%)

10 (19.2%)

 No

101 (70.1%)

51 (75.0%)

97 (70.3%)

42 (80.8%)

Tracheotomy at last follow-up

.67

.21

 Yes

20 (13.9%)

8 (11.8%)

20 (14.5%)

4 (7.7%)

 No

124 (86.1%)

60 (88.2%)

118 (85.5%)

48 (92.3%)

AKI during RT

<.001

<.01

 Yes

72 (50.0%)

15 (22.1%)

68 (49.3%)

15 (28.9%)

 No

40 (27.8%)

40 (58.8%)

39 (28.3%)

29 (55.8%)

 Not stated

32 (22.2%)

13 (19.1%)

31 (%)

8 (15.4%)